DYNO FRONTIERS
LIVE

Serial Number

99932830

Owner

Dyno Therapeutics, Inc.

Attorney

William R. Samuels

First Use Date

May 14, 2025

Filing Date

Jul 10, 2026

Add to watchlist:

No watchlists yet
View on USPTO

DYNO FRONTIERS Trademark

Serial Number: 99932830

DYNO FRONTIERS is a trademark filed by Dyno Therapeutics, Inc. on July 10, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Dyno Therapeutics, Inc. (21 trademarks)

Suite 101
Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

July 10, 2026

Registration Date

Not Registered

First Use Anywhere

May 14, 2025

First Use in Commerce

May 14, 2025

Goods & Services

Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharing services in the fields of biotechnology, gene therapy, and viral capsid technology, namely, coordinating the exchange of scientific and technical data among network participants

Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies

Association services, namely, promoting the interests of gene therapy developers, manufacturers, and research organizations in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; business networking services in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; facilitating business connections and collaboration among organizations engaged in gene therapy development, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; administration of a business network in the fields of genetic medicine, gene therapy, gene delivery, and viral capsid technology

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 10, 2026 MAFR
NEW APPLICATION ENTERED
Jul 10, 2026 NWAP